- Certain Birth Control Pills, Devices Linked to Higher Heart Risks
- Ready for a Romantic Relationship? Your Friends’ Opinions Matter
- More Sunshine in Pregnancy, Infancy Could Benefit Kids With MS
- Enjoying Valentine’s Day When a Loved One Has Alzheimer’s
- Could Yogurt Lower Your Odds for Deadly Colon Cancers?
- Senators Call on FDA to Act Against Misleading Weight-Loss Drug Commercials
- Canned Tuna Recalled in Dozens of States Over Risk of Food Poisoning
- More Evidence Ozempic Can Curb Alcoholism
- In People With Autism, ADHD Rates Still Common in Adulthood
- Almost Half of Rural Americans Face Long Drives for Surgery
New System Targets Germs in Donated Blood Plasma

A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.
The Intercept Blood System for plasma targets germs including AIDS-causing HIV, hepatitis B and C, and the West Nile virus, the FDA said in a news release.
The system uses controlled exposure to ultraviolet light and a germ-targeting chemical called amotosalen, the agency said. The plasma is then purified to remove the chemical and any byproducts.
While the system has proven effective, no system or device has been shown to eliminate all germs. The Intercept system hasn’t been effective, for example, in eliminating the human parvovirus B19 and spores formed by certain bacteria, the FDA said.
The system’s clinical safety and effectiveness were evaluated in studies involving more than 700 people.
Side effects were comparable to those among people who received untreated plasma, the agency said.
The Intercept system is marketed by Cerus Corp., based in Concord, Calif.
More information
Visit the FDA to learn more.
Source: HealthDay
Copyright © 2025 HealthDay. All rights reserved.